The latest market report published by Credence Research, Inc. “Global Robotic Lung Biopsy Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global robotic lung biopsy market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 9.20% between 2023 and 2030. The market was valued at USD 385.9 million in 2022 and is expected to reach USD 714.6 million in 2030.
Robotic Lung Biopsy Market has experienced remarkable growth, driven by advancements in robotics and artificial intelligence, resulting in enhanced precision, low invasiveness, and increased efficiency in procedures. The demand for robotic lung biopsies has surged, primarily due to the growing need for early identification and detection of lung cancer, leading to a rise in minimally invasive medical procedures. These advancements in technology have enabled safer and more efficient treatments, reducing discomfort, recuperation time, and infection risk. Early diagnosis of lung cancer and other respiratory disorders has become crucial, contributing to the market’s substantial growth and innovation opportunities in the healthcare industry.
The global robotic lung biopsy market is segmented based on product and services, navigation technology, end-users, and regions. Instruments and accessories dominate the market, while the system segment is expected to exhibit the fastest growth rate. Among navigation technologies, fiber optic real-shape navigation holds the highest compound annual growth rate (CAGR). In terms of end-users, hospitals dominate the market, with North America leading in market growth.
Robotic Lung Biopsy Market Major Challenges revolve around the adoption of robotic technology in an already complex and sensitive medical procedure. One of the significant challenges is the high cost associated with acquiring and maintaining robotic systems, which can be a deterrent for healthcare facilities with limited budgets. Moreover, integrating robotics into existing workflows requires extensive training for medical professionals, as they need to familiarize themselves with new tools and techniques. Another challenge lies in ensuring accurate targeting during biopsies since any deviation or error may lead to complications or inaccurate diagnosis. Additionally, there are concerns regarding patient safety and trust in relying on machines during critical procedures like lung biopsies.
Browse 250 pages report Robotic Lung Biopsy Market By Product and Services (System, Instruments and Accessories, Service) By Navigation Technology (Electromagnetic and Optical Navigation, Fiber Optic Real Shape Navigation) By End User (Hospitals, Ambulatory Surgical Centers) -Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/robotic-lung-biopsy-market
Benefits Offered by Robotic Lung Biopsy
Robotic lung biopsies have gained significant momentum due to their contribution to early cancer detection, minimally invasive treatments, reduced discomfort, shorter recovery times, and decreased infection risks. Early diagnosis allows for timely and appropriate treatment approaches, leading to improved patient outcomes.
Pressing Need for Surgical Precision
Robotic-assisted surgery, with precise instrument positioning and advancements in robot-guided instrument positioning, has streamlined surgical procedures and improved patient outcomes. This technology has particularly benefited orthopedic and neurosurgery operations, laser therapy, tumor removal, and biopsy procedures.
High Cost and Scarcity of Quality Healthcare
The initial capital costs for robotic systems and the scarcity of trained medical personnel may restrain industry expansion, particularly in low-income countries with limited healthcare budgets. Strong regulatory frameworks are required to monitor the development and use of medical devices with robotic assistance, ensuring product safety and compliance.
The market is highly competitive, with key players such as Intuitive Surgical, Harron Lung Center, Community Health Network, Ethicon Inc. (Johnson & Johnson), Shanghai MicroPort MedBot (Group) Co. Ltd., Noah Medical, and Siemens Healthineers leading the way. These companies focus on product innovation, expanding distribution channels, and mergers and acquisitions to maintain a competitive edge.
Why to Buy This Report-
- The report provides a qualitative as well as quantitative analysis of the global Robotic Lung Biopsy Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
- The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
- Major nations in each region with their import/export statistics
- The global Robotic Lung Biopsy Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/robotic-lung-biopsy-market
Related Report: https://www.credenceresearch.com/report/medical-animation-market
Browse Our Blog: https://tealfeed.com/robotic-lung-biopsy-market-size-expected-jgd3h
About Us –
Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.
Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India